An Evaluation of the Effectiveness of Local Anesthetics Used During Intravenous Catheter Insertion

July 29, 2014 updated by: Duke University
The purpose of this study is to compare how well different anesthetic, or numbing, solutions injected under the skin work in reducing the discomfort associated with placing a catheter in a vein. Two different medications, lidocaine and normal saline with benzyl alcohol, have been found to be effective in reducing discomfort when injected under the skin just prior to inserting the catheter. This study compares these two solutions, and will compare the discomfort that occurs both with and without using these solutions.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

99

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult patients (aged 18 or older)
  • admitted to a general medical or surgical unit at Durham Regional Hospital (DRH)
  • have a physician's order for an IV
  • are able to speak, read and understand English
  • referred to the Vascular Access Specialty Team (VAST) at DRH for IV catheterization

Exclusion Criteria:

  • admission to the emergency room, pre-op unit, an outpatient unit, a psychiatric unit, an intensive care unit, a pre- or postnatal care unit, or labor and delivery units;
  • history of a psychological disorder, as determined from the patient's chart;
  • history of peripheral neuropathy, as determined by patient's chart;
  • history of IV drug abuse, as determined from the patient's chart;
  • decreased sensation in the arm or hands, as reported in the chart or by the patient;
  • patient disorientation or confusion (i.e., unable to state person, place, time or unable to comprehend instructions for completing Visual Analog Scale);
  • a known allergy to lidocaine or benzyl alcohol as determined from the patient's chart;
  • veins that cannot be palpated and are difficult to visualize by VAST nurses;
  • pregnancy;
  • an order for the emergency insertion of an IV by the patient's doctor or assigned nurse;
  • an IV insertion that requires the use of a catheter gauged 18 or larger
  • severe vision impairment, as determined by the patient's inability to read the Visual Analogue Scale

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: lidocaine
1% lidocaine intradermal injection
ACTIVE_COMPARATOR: bacteriostatic normal saline (BNS)
bacteriostatic normal saline (BNS) injection
NO_INTERVENTION: no local anesthetic
usual care practice of no local anesthetic administration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences in Patients' Perceptions of Pain Between Treatment Methods
Time Frame: at pre injection, during anesthetic injection, and during catheter insertion, up to approximately 1 minute
The visual analog pain scale is a patient-reported measure of pain on a 10-point scale with 0 being no pain and 10 being worst possible pain. The visual analog pain score will be completed at the following time points: pre injection, during injection, and during catheter insertion.
at pre injection, during anesthetic injection, and during catheter insertion, up to approximately 1 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Julia Aucoin, DNS, RN, Duke Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2010

Primary Completion (ACTUAL)

July 1, 2011

Study Completion (ACTUAL)

July 1, 2011

Study Registration Dates

First Submitted

June 11, 2014

First Submitted That Met QC Criteria

June 11, 2014

First Posted (ESTIMATE)

June 13, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

August 15, 2014

Last Update Submitted That Met QC Criteria

July 29, 2014

Last Verified

June 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on IV Insertion Pain

Clinical Trials on 1% lidocaine

Subscribe